Scenarios

Ms G has been using Gina for three months. Her symptoms have improved and she is now able to ride her bike again. When going through the Pharmacy Checklist, she tells you that since she purchased her last pack, she had a problem with one of her legs and has been told that she has a blood clot.
Can you supply Gina?
IncorrectShe should be referred to
her GP to discuss the risk first

Mrs F asks if she would be suitable for Gina. Her GP has been prescribing intravaginal oestrogen creams for the past 6 months to manage her VA symptoms. She is happy with the symptom improvement she has experienced but she finds it difficult to take time off of work to go to her GP. She thinks that getting a similar product from pharmacy will be more convenient for her. She tells you that she is 60 years old and her last period was well over 5 years ago. There have been no changes to her or her family's health status since her last prescription and she has no contraindications to Gina.
Can you supply Gina?
IncorrectWomen who have been using local oestrogen therapy for more than 3 months at the recommended dose and whose symptoms are adequately controlled can be switched to Gina and start on the maintenance dose. If symptom control is affected by a lower oestrogen dose she should discuss this with her GP
Click continue to assessment to answer some further questions to test your understanding and record this learning in your learning log.
Pharmacists and pharmacy technicians can use this training module to help support their GPhC revalidation.
*The content of the Pharmacy Guide for the Supply of Gina and the Pharmacy Checklist are not covered by the NPA seal.
The content of this material has been approved by the NPA. The NPA will have no liability to any person or entity with liability, loss or damage caused or alleged to have been caused directly or indirectly by information therein. The NPA is not responsible for the content of any non-NPA websites mentioned in this programme or for the accuracy of any information found there. The fact that a website, organisation or product is mentioned in the programme does not mean that the NPA either approves of it or endorses it.
1. Novo Nordisk. Pharmacy Guide for the Supply of Gina [2022]. https://www.medicines.org.uk/emc/rmm/2509/Document (accessed June 2022)
Further information about this product, including essential supply information, adverse reactions, precautions, contraindications, and method of use can be found at: https://www.emcpi.com/pi/41923
